التفاصيل البيبلوغرافية
العنوان: |
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients |
المؤلفون: |
Zwaginga, J.J. (Jaap), Holt, B. (Bronno) van der, Boekhorst, P.A.W. (Peter) te, Biemond, B.J. (Bart), Levin, M.-D. (Mark-David), Griend, R. (René) van der, Brand, A. (Anneke), Zweegman, S. (Sonja), Pruijt, H.F.M. (Hans), Novotny, V.M.J. (Vera), Vreugdenhil, A. (Art), Groot, M.R. (Marco) de, Weerdt, O. (Okke) de, Pampus, E.C.M. (Elisabeth) van, Maanen-Lamme, T.M. (Tanja) van, Wittebol, S. (Shulamit), Schipperus, M.R. (Martin), Silbermann, M.H. (Matthijs), Huijgens, P.C. (Peter), Luten, M. (Marleen), Hollestein, R. (Rene), Brakenhoff, J.A.C. (Jan), Schrama, J.G. (Jolanda), Valster, F.A.A. (Fransje), Velders, G.A. (Gerjo), Koene, H.R. (Harry) |
المصدر: |
Haematologica vol. 100 no. 3, pp. e90-e92 |
سنة النشر: |
2015 |
المجموعة: |
RePub - Publications from Erasmus University, Rotterdam |
مصطلحات موضوعية: |
Early response, Immune thrombocytopenia, Open label phase II, Rituximab, Splenectomy delaying |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
العلاقة: |
http://repub.eur.nl/pub/89667Test; urn:hdl:1765/89667 |
DOI: |
10.3324/haematol.2014.110213 |
الإتاحة: |
https://doi.org/10.3324/haematol.2014.110213Test http://repub.eur.nl/pub/89667Test |
حقوق: |
info:eu-repo/semantics/openAccess |
رقم الانضمام: |
edsbas.B0260747 |
قاعدة البيانات: |
BASE |